6 completed, 1 recruiting, 1 unknown. 8 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 8 | Completed 6, Recruiting 1, Unknown 1 |
Follow Cannabis: new trials by email Literature Review of Cannabis trials Research Report on Cannabis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeated CBD Administration and Cannabis Outcomes Cannabidiol, Medium Dose, Cannabidiol, Higher Dose, Active Inhaled Cannabis - Cannabis, Abuse Liability | Early Phase 1 | Recruiting | Hannah Harris | 23 | 2026-08-05 | 2026-08-12 |
| Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise Cannabis - Cannabis, Cardiovascular Risk Factor | Early Phase 1 | Completed | Jamie Burr | 22 | 2021-09-01 | 2025-04-18 |
| The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients cannabis - Retinitis Pigmentosa, Retinal Degeneration | Early Phase 1 | Unknown | Hadassah Medical Organization | 50 | 2018-09-01 | 2021-02-12 |
| Tetrahydrocannabinol (THC) and Sleep Dronabinol - Sleep, THC | Early Phase 1 | Completed | Oregon Health and Science University | 18 | 2018-09-01 | 2026-02-05 |
| Imaging the Neurochemistry of Drug Addiction With PET cannabis - Smoking, Cannabis | Early Phase 1 | Completed | Yale University | 25 | 2017-11-29 | 2024-12-12 |
| Cannabinoids and Cerebellar-Motor Functioning THC, Placebo - Cannabis, Psychotic Disorders | Early Phase 1 | Completed | Yale University | 57 | 2012-12-01 | 2024-09-19 |
| Dronabinol Interactions With Cognitive Enhancing Drug in Humans drug condition - Cannabis, Marijuana Abuse | Early Phase 1 | Completed | Yale University | 53 | 2008-09-01 | 2017-05-30 |
| Cannabinoids, Neural Synchrony, and Information Processing THC, Placebo - Cannabis, Psychotic Disorders | Early Phase 1 | Completed | Yale University | 42 | 2008-02-25 | 2022-03-09 |
Marijuana Abuse (8) · Psychotic Disorders (2) · Retinal Degeneration (1) · Retinitis Pigmentosa (1) · Smoking (1)
Chemically-Induced Disorders (8) · Mental Disorders (8) · Substance-Related Disorders (8) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Behavior (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Retinal Diseases (1) · Retinal Dystrophies (1)
Dronabinol (5) · nabiximols (3) · Cannabidiol (2) · Modafinil (1)
Yale University (4) · Hadassah Medical Organization (1) · Hannah Harris (1) · Jamie Burr (1) · Oregon Health and Science University (1)
United States (6) · Canada (1) · Israel (1)
Deepak D'Souza, MD (1) · Hadas Mechoulam, MD (1) · Hannah M Harris, Ph.D. (1) · Kelly Cosgrove, PhD (1) · Mehmet Sofuoglu, M.D,Ph.D. (1) · Steven A Shea, PhD (1)
PMID 21176784, PMID 28642081, PMID 34399137, PMID 34532852, PMID 36314198, PMID 39575727
K01DA056692 (1), P50DA009241 (1), R01DA038709 (1), R01DA038832 (1), R03DA047588 (1), R21DA020750 (1)